Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COSTAIN GROUP PLC Board/Management Information 2026

Feb 24, 2026

4669_rns_2026-02-24_1eb6979a-7ebb-4b14-a6c9-ed122ef07cb8.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2272U

Costain Group PLC

24 February 2026

Image 

Costain Group PLC (Costain)

24 February 2026

External Appointment

Costain confirms that, as announced by Chemring Group PLC (Chemring), on 10 November 2025. Fiona MacAulay, a Non-Executive Director of Costain, Chair of the Remuneration Committee and member of the Audit and Risk Committee and Nomination Committee, did not seek re-election at the Chemring AGM on 20 February 2026 and has therefore retired from the Board of Chemring.

Additionally, in accordance with UK Listing Rule 6.4.9R(2), Costain has been advised that following the completion of the acquisition and merger of Dowlais Group plc into Dauch Corporation (formally American Axel & Manufacturing), Fiona became an independent director of Dauch Corporation, which is listed on the London Stock Exchange and the New York Stock Exchange with effect from 3 February 2026.

Enquiries

Investors and analysts [email protected]
Matthew Jones, Costain +44 (0) 7860 922 341
Company Secretariat [email protected]
Katie Mullins +44 (0) 7353 006 675
Cyd Trumper +44 (0) 7879 133 084

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNKZGZZKDKGVZM